METTL14 and ovarian carcinoma: Similar to these findings, our current data showed that METTL14 had a significant reduction in CNVs in ovarian cancer tissues and that METTL14 overexpression inhibited ovarian cancer cell proliferation in vitro, further confirming the TCGA and GEO data.